{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:57:25Z","timestamp":1791291445350,"version":"4.3.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":1096,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1038\/jid.2012.226","type":"journal-article","created":{"date-parts":[[2012,7,19]],"date-time":"2012-07-19T08:21:37Z","timestamp":1342686097000},"page":"2752-2761","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["IL-6 Blockade Attenuates the Development of Murine Sclerodermatous Chronic Graft-Versus-Host Disease"],"prefix":"10.1016","volume":"132","author":[{"given":"Doanh","family":"Le Huu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Matsushita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guihua","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhito","family":"Hamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoru","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Takehara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manabu","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/jid.2012.226_bb0010","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1172\/JCI17601","article-title":"Memory CD4+ T cells do not induce graft-versus-host disease","volume":"112","author":"Anderson","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1038\/jid.2012.226_bb0015","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature04753","article-title":"Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells","volume":"441","author":"Bettelli","year":"2006","journal-title":"Nature"},{"key":"10.1038\/jid.2012.226_bb0020","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1182\/blood-2009-01-197178","article-title":"Blockade of interleukin-6 signaling augments regulatory T-cell reconstitution and attenuates the severity of graft-versus-host disease","volume":"114","author":"Chen","year":"2009","journal-title":"Blood"},{"key":"10.1038\/jid.2012.226_bb0025","doi-asserted-by":"crossref","first-page":"3804","DOI":"10.1182\/blood-2007-05-091074","article-title":"Absence of regulatory T-cell control of TH1 and TH17 cells is responsible for the autoimmune-mediated pathology in chronic graft-versus-host disease","volume":"110","author":"Chen","year":"2007","journal-title":"Blood"},{"key":"10.1038\/jid.2012.226_bb0030","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.bbmt.2007.12.002","article-title":"Murine models of chronic graft-versus-host disease: insights and unresolved issues","volume":"14","author":"Chu","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1038\/jid.2012.226_bb0035","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0008-8749(85)90086-3","article-title":"Chronic graft-versus-host disease as a model for scleroderma. II. Mast cell depletion with deposition of immunoglobulins in the skin and fibrosis","volume":"94","author":"Claman","year":"1985","journal-title":"Cell Immunol"},{"key":"10.1038\/jid.2012.226_bb0040","series-title":"StemBook","article-title":"Mouse models of graft-versus-host disease","author":"Ferrara","year":"2009"},{"key":"10.1038\/jid.2012.226_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jdermsci.2010.08.010","article-title":"Regulatory B cells in skin and connective tissue diseases","volume":"60","author":"Fujimoto","year":"2010","journal-title":"J Dermatol Sci"},{"key":"10.1038\/jid.2012.226_bb0050","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s10067-010-1610-4","article-title":"Serum chemokine and cytokine levels as indicators of disease activity in patients with systemic sclerosis","volume":"30","author":"Hasegawa","year":"2011","journal-title":"Clin Rheumatol"},{"key":"10.1038\/jid.2012.226_bb0055","first-page":"308","article-title":"Serum levels of interleukin 6 (IL-6), oncostatin M, soluble IL-6 receptor, and soluble gp130 in patients with systemic sclerosis","volume":"25","author":"Hasegawa","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1038\/jid.2012.226_bb0060","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jdermsci.2007.05.014","article-title":"Autocrine TGF-beta signaling in the pathogenesis of systemic sclerosis","volume":"49","author":"Ihn","year":"2008","journal-title":"J Dermatol Sci"},{"key":"10.1038\/jid.2012.226_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0008-8749(83)90001-1","article-title":"Chronic graft-versus-host disease (GVHD) as a model for scleroderma. I. Description of model systems","volume":"77","author":"Jaffee","year":"1983","journal-title":"Cell Immunol"},{"key":"10.1038\/jid.2012.226_bb0070","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1146\/annurev-pathol-011110-130312","article-title":"The pathogenesis of systemic sclerosis","volume":"6","author":"Katsumoto","year":"2011","journal-title":"Annu Rev Pathol: Mech Dis"},{"key":"10.1038\/jid.2012.226_bb0075","doi-asserted-by":"crossref","first-page":"12099","DOI":"10.1073\/pnas.0705268104","article-title":"IL-6-dependent and -independent pathways in the development of interleukin 17-producing T helper cells","volume":"104","author":"Kimura","year":"2007","journal-title":"Pro Natl Acad Sci USA"},{"key":"10.1038\/jid.2012.226_bb0080","doi-asserted-by":"crossref","first-page":"4763","DOI":"10.4049\/jimmunol.180.7.4763","article-title":"TLR-activated B cells suppress T cell-mediated autoimmunity","volume":"180","author":"Lampropoulou","year":"2008","journal-title":"J Immunol"},{"key":"10.1038\/jid.2012.226_bb0085","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s12185-011-0803-1","article-title":"Implications of TNF-alpha in the pathogenesis and management of GVHD","volume":"93","author":"Levine","year":"2011","journal-title":"Int J Hematol"},{"key":"10.1038\/jid.2012.226_bb0090","first-page":"275","article-title":"Longitudinal analysis of serum cytokine concentrations in systemic sclerosis: association of interleukin 12 elevation with spontaneous regression of skin sclerosis","volume":"33","author":"Matsushita","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1038\/jid.2012.226_bb0095","first-page":"3420","article-title":"Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression","volume":"118","author":"Matsushita","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1038\/jid.2012.226_bb0100","doi-asserted-by":"crossref","first-page":"5693","DOI":"10.4049\/jimmunol.163.10.5693","article-title":"Anti-TGF-beta treatment prevents skin and lung fibrosis in murine sclerodermatous graft-versus-host disease: a model for human scleroderma","volume":"163","author":"McCormick","year":"1999","journal-title":"J Immunol"},{"key":"10.1038\/jid.2012.226_bb0105","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1046\/j.1365-2249.1998.00612.x","article-title":"IL-6 receptor blockage inhibits the onset of autoimmune kidney disease in NZB\/W F1 mice","volume":"112","author":"Mihara","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"10.1038\/jid.2012.226_bb0110","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.expneurol.2010.04.020","article-title":"Anti-IL-6-receptor antibody promotes repair of spinal cord injury by inducing microglia-dominant inflammation","volume":"224","author":"Mukaino","year":"2010","journal-title":"Exp Neurol"},{"key":"10.1038\/jid.2012.226_bb0115","doi-asserted-by":"crossref","first-page":"3959","DOI":"10.1182\/blood-2008-05-155846","article-title":"Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease","volume":"112","author":"Nishimoto","year":"2008","journal-title":"Blood"},{"key":"10.1038\/jid.2012.226_bb0120","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1182\/blood-2005-06-2529","article-title":"Mucosal FOXP3+ regulatory T cells are numerically deficient in acute and chronic GvHD","volume":"107","author":"Rieger","year":"2006","journal-title":"Blood"},{"key":"10.1038\/jid.2012.226_bb0125","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0923-1811(01)00128-1","article-title":"Serum levels of interleukin-6 and interleukin-10 correlate with total skin thickness score in patients with systemic sclerosis","volume":"27","author":"Sato","year":"2001","journal-title":"J Dermatol Sci"},{"key":"10.1038\/jid.2012.226_bb0130","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1365-2249.2004.02642.x","article-title":"Cytokine and chemokine levels in systemic sclerosis: relationship with cutaneous and internal organ involvement","volume":"138","author":"Scala","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"10.1038\/jid.2012.226_bb0135","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00430-006-0019-9","article-title":"Interleukin-6 and its receptor: from bench to bedside","volume":"195","author":"Scheller","year":"2006","journal-title":"Med Microbiol Immunol"},{"key":"10.1038\/jid.2012.226_bb0140","doi-asserted-by":"crossref","first-page":"9041","DOI":"10.1073\/pnas.0802218105","article-title":"IL-6 blockade inhibits the induction of myelin antigen-specific Th17 cells and Th1 cells in experimental autoimmune encephalomyelitis","volume":"105","author":"Serada","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/jid.2012.226_bb0145","first-page":"17","article-title":"Elevated serum interleukin-6 levels associated with active disease in systemic connective tissue disorders","volume":"13","author":"Stuart","year":"1995","journal-title":"Clin Exp Rheumatol"},{"key":"10.1038\/jid.2012.226_bb0150","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1002\/art.27428","article-title":"Inducible costimulator ligand regulates bleomycin-induced lung and skin fibrosis in a mouse model independently of the inducible costimulator\/inducible costimulator ligand pathway","volume":"62","author":"Tanaka","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1038\/jid.2012.226_bb0155","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1158\/1078-0432.CCR-10-1198","article-title":"Interleukin-6 modulates graft-versus-host responses after experimental allogeneic bone marrow transplantation","volume":"17","author":"Tawara","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1038\/jid.2012.226_bb0160","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2174\/1573397052954109","article-title":"Characteristics of animal models for scleroderma","volume":"1","author":"Toshiyuki","year":"2005","journal-title":"Curr Rheumatol Rev"},{"key":"10.1038\/jid.2012.226_bb0165","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/j.intimp.2008.07.002","article-title":"Anti-IL-6 receptor antibody increases blood IL-6 level via the blockade of IL-6 clearance, but not via the induction of IL-6 production","volume":"8","author":"Uchiyama","year":"2008","journal-title":"Int Immunopharmacol"},{"key":"10.1038\/jid.2012.226_bb0170","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1172\/JCI31139","article-title":"Systemic sclerosis: a prototypic multisystem fibrotic disorder","volume":"117","author":"Varga","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1038\/jid.2012.226_bb0175","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.immuni.2006.01.001","article-title":"TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells","volume":"24","author":"Veldhoen","year":"2006","journal-title":"Immunity"},{"key":"10.1038\/jid.2012.226_bb0180","doi-asserted-by":"crossref","first-page":"560","DOI":"10.2353\/ajpath.2007.061279","article-title":"CD19 expression in B cells is important for suppression of contact hypersensitivity","volume":"171","author":"Watanabe","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1038\/jid.2012.226_bb0185","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.immuni.2008.03.017","article-title":"A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses","volume":"28","author":"Yanaba","year":"2008","journal-title":"Immunity"},{"key":"10.1038\/jid.2012.226_bb0190","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.4049\/jimmunol.168.6.3088","article-title":"Murine sclerodermatous graft-versus-host disease, a model for human scleroderma: cutaneous cytokines, chemokines, and immune cell activation","volume":"168","author":"Zhang","year":"2002","journal-title":"J Immunol"},{"key":"10.1038\/jid.2012.226_bb0195","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/sj.jid.5700517","article-title":"Cutaneous gene expression by DNA microarray in murine sclerodermatous graft-versus-host disease, a model for human scleroderma","volume":"127","author":"Zhou","year":"2007","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2012.226_bb0200","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1146\/annurev-immunol-030409-101212","article-title":"Differentiation of effector CD4 T cell populations (*)","volume":"28","author":"Zhu","year":"2010","journal-title":"Annu Rev Immunol"},{"key":"10.1038\/jid.2012.226_bb0205","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1182\/blood-2005-03-1257","article-title":"Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease","volume":"106","author":"Zorn","year":"2005","journal-title":"Blood"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15355585?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15355585?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T17:43:24Z","timestamp":1743961404000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X15355585"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":40,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S0022202X15355585"],"URL":"https:\/\/doi.org\/10.1038\/jid.2012.226","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IL-6 Blockade Attenuates the Development of Murine Sclerodermatous Chronic Graft-Versus-Host Disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/jid.2012.226","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 The Society for Investigative Dermatology, Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}